Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNO 1016 in Chronic Rhinosinusitis
NCT01706484Phase 3Completed
- Sponsor
- Bionorica
- Start
- Sep 2012
- Primary completion
- Apr 2014
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 3 trial of Sambucus nigra flower in chronic rhinosinusitis (CRS), sponsored by Bionorica. Started Sep 2012; status: completed.
02
Drugs
Sambucus nigra flower
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT01706484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01706484.